Product image of Momanose (Mometasone Furoate) supplied by GNH India

Momanose

Active Ingredient:
Mometasone Furoate
Origin:
EU

Momanose (Mometasone Furoate)

Mometasone furoate, the active ingredient in Momanose, is a corticosteroid presented as a nasal spray for nasal administration. It is indicated for the management of allergic rhinitis, including seasonal and perennial forms, as well as nasal polyps, providing anti‑inflammatory relief in both adult and pediatric patients.

GNH India supplies Momanose as a licensed, Good Distribution Practice‑compliant international pharmaceutical supplier, delivering the product to hospitals, pharmacies and clinics worldwide in accordance with regulatory standards and supporting local procurement teams with reliable logistics.

Manufacturer / TM Owner

Sandoz S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Momanose, a nasal corticosteroid, is used to treat inflammatory conditions of the nasal passages.

  • Allergic rhinitis: reduces nasal congestion, sneezing and itching.
  • Seasonal allergic rhinitis: provides symptom relief during pollen exposure.
  • Perennial allergic rhinitis: controls year‑round nasal inflammation.
  • Nasal polyps: helps shrink polyps and improve airflow.

How It Works

  • Mometasone furoate acts as an agonist of glucocorticoid receptors in the nasal mucosa. Binding to these intracellular receptors modulates gene transcription, leading to decreased production of inflammatory cytokines, prostaglandins and leukotrienes. The resulting anti‑inflammatory and immunosuppressive effects reduce mucosal edema, mucus secretion and cellular infiltration, thereby alleviating nasal symptoms. It also stabilizes mast cells, limiting histamine release and further contributing to symptom control.

Side Effects

Momanose may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Nasal irritation or burning sensation.
  • Epistaxis (nosebleeds).
  • Headache.
  • Throat irritation or dryness.
  • Cough.
  • Altered taste perception.

Serious or Rare Side Effects

  • Adrenal suppression with prolonged use.
  • Glaucoma or cataract formation.
  • Severe allergic reaction (anaphylaxis).
  • Nasal septal perforation.
  • Opportunistic fungal infection of the nasal mucosa.
  • Systemic immunosuppression leading to increased infection risk.

Precautions & Warnings

Before using Momanose, consider the following precautions.

  • Assess patient history: evaluate for nasal infections or recent surgery before initiating therapy.
  • Avoid prolonged use: limit duration as advised by healthcare professional to reduce risk of systemic effects.
  • Monitor for ocular symptoms: report vision changes that could indicate glaucoma or cataracts.
  • Use with caution in children: follow pediatric dosing guidelines and watch for growth suppression.
  • Avoid concomitant intranasal decongestants: may increase local irritation.
  • Store at room temperature: keep below 25°C, protect from moisture and direct sunlight.

Avoid Interactions

Momanose may interact with other medicines; review the following.

Major Interactions (Avoid)

  • Systemic corticosteroids: may increase risk of systemic glucocorticoid effects.
  • Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise local drug exposure.
  • Live vaccines: immunosuppression may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely)

  • Antifungal azoles (e.g., itraconazole): may modestly increase exposure.
  • Ritonavir: may affect metabolism of the nasal corticosteroid.
  • Nasal antihistamines: may cause additive local irritation.

Frequently Asked Questions

Momanose is a nasal spray containing mometasone furoate and is prescribed for the treatment of allergic rhinitis—including both seasonal and perennial types—as well as for managing nasal polyps. It helps reduce nasal congestion, sneezing, itching, and improves overall nasal airflow.

Mometasone furoate binds to glucocorticoid receptors in the cells of the nasal mucosa. This interaction alters gene expression, decreasing the release of inflammatory mediators such as cytokines, prostaglandins, and leukotrienes, which reduces swelling, mucus production, and immune cell infiltration in the nasal passages.

The appropriate dose of Momanose is determined by the prescribing healthcare professional based on the patient’s age, severity of symptoms, and clinical response. Dosage instructions are individualized and should be followed exactly as written on the prescription label.

Safety data for Momanose in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare provider.

To order Momanose, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Momanose (mometasone furoate) is a high‑potency nasal corticosteroid with a low systemic bioavailability, similar to other agents such as fluticasone propionate. Clinical studies suggest comparable efficacy in relieving allergic rhinitis symptoms, while its once‑daily dosing and favorable safety profile make it a convenient option for many patients.

Momanose should be stored at room temperature, below 25 °C (77 °F). Keep the spray bottle in its original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed when not in use.

Momanose is administered as a nasal spray. The patient should gently blow the nose, tilt the head slightly forward, insert the tip into one nostril, and press the actuator while breathing in gently through the nose. The recommended number of sprays per nostril is specified by the prescriber.

Serious risks, though rare, include adrenal suppression with long‑term use, development of glaucoma or cataracts, severe allergic reactions such as anaphylaxis, and nasal septal perforation. Patients should report any unusual visual changes, persistent nosebleeds, or signs of infection promptly.

Momanose should be avoided in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It is also contraindicated in patients with active untreated nasal infections, recent nasal surgery, or those who have experienced severe local irritation from other intranasal corticosteroids.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT